Current:Home > MarketsThe FDA finalizes rule expanding the availability of abortion pills-LoTradeCoin
The FDA finalizes rule expanding the availability of abortion pills
View Date:2024-12-23 23:18:55
WASHINGTON — The Food and Drug Administration on Tuesday finalized a rule change that broadens availability of abortion pills to many more pharmacies, including large chains and mail-order companies.
The Biden administration partially implemented the change last year, announcing it would no longer enforce a long-standing requirement that women pick up the medicine in person. Tuesday's action formally updates the drug's labeling to allow many more retail pharmacies to dispense the pills, so long as they complete a certification process.
The change could expand access at both brick-and-mortar stores and online pharmacies. Women can get a prescription via telehealth consultation with a health professional, and then receive the pills through the mail, where permitted by law.
Still, the rule change's impact has been blunted by numerous state laws limiting abortion broadly and the pills specifically. Legal experts foresee years of court battles over access to the pills, as abortion-rights proponents bring test cases to challenge state restrictions.
For more than 20 years, the FDA labeling had limited dispensing to a subset of specialty offices and clinics, due to safety concerns. During the COVID-19 pandemic, the FDA temporarily suspended the in-person requirement. The agency later said a new scientific review by agency staff supported easing access, concurring with numerous medical societies that had long said the restriction wasn't necessary.
Two drugmakers that make brand-name and generic versions of abortion pills requested the latest FDA label update. Agency rules require a company to file an application before modifying dispensing restrictions on drugs.
Danco Laboratories, which sells branded Mifeprex, said in a statement the change "is critically important to expanding access to medication abortion services and will provide healthcare providers" with another option for prescribing the drug.
The American College of Obstetricians and Gynecologists called the update an "important step" forward.
"Although the FDA's announcement today will not solve access issues for every person seeking abortion care, it will allow more patients who need mifepristone for medication abortion additional options to secure this vital drug," the group said in a statement.
More than half of U.S. abortions are now done with pills rather than surgery, according to the Guttmacher Institute, a research group that supports abortion rights.
The FDA in 2000 approved mifepristone to terminate pregnancies of up to 10 weeks, when used with a second drug, misoprostol. Mifepristone is taken first to dilate the cervix and block the hormone progesterone, which is needed to sustain a pregnancy. Misoprostol is taken 24 to 48 hours later, causing the uterus to contract and expel pregnancy tissue.
Bleeding is a common side effect, though serious complications are very rare. The FDA says more than 3.7 million U.S. women have used mifepristone since its approval.
Several FDA-mandated safety requirements remain in effect, including training requirements to certify that prescribers can provide emergency care in the case of excessive bleeding. Pharmacies that dispense the pills also need a certification.
veryGood! (319)
Related
- 12 college students charged with hate crimes after assault in Maryland
- Here's what you need to know to prep for Thanksgiving
- 3 dead, including the suspect, after shooting in Pennsylvania apartment and 40-mile police chase
- Study: Weather extremes are influencing illegal migration and return between the U.S. and Mexico
- Democrat Janelle Bynum flips Oregon’s 5th District, will be state’s first Black member of Congress
- Meet the 2025 Grammys Best New Artist Nominees
- Quincy Jones' Daughter Rashida Jones Shares Most Precious Memory After His Death
- Martha Stewart’s Ex-Husband Andy Stewart Calls Out Her Claims in Sensationalized Documentary
- Democrat Janelle Bynum flips Oregon’s 5th District, will be state’s first Black member of Congress
- South Carolina, Iowa among five women's college basketball games to watch this weekend
Ranking
- Man found dead in tanning bed at Indianapolis Planet Fitness; family wants stricter policies
- Monkeys still on the loose in South Carolina as authorities scramble to recapture them
- Beyoncé is the leading nominee for 2025 Grammys with 11 nods, becoming most nominated ever
- New York bank manager sentenced to prison for stealing over $200K from dead customer: DOJ
- Parts of Southern California under quarantine over oriental fruit fly infestation
- Kasha-Katuwe Tent Rocks National Monument in New Mexico is set to reopen
- How Trump's victory could affect the US economy
- Liam Payne Case: 3 People Charged With Abandonment of Person Followed by Death
Recommendation
-
What is prize money for NBA Cup in-season tournament? Players get boost in 2024
-
Parents of 4-year-old who starved to death in NYC apartment charged with murder
-
San Francisco’s first Black female mayor concedes to Levi Strauss heir
-
San Francisco police asking for help locating 18-year-old woman missing since Halloween
-
Should Georgia bench Carson Beck with CFP at stake against Tennessee? That's not happening
-
43 monkeys remain on the run from South Carolina lab. CEO says he hopes they’re having an adventure
-
Kyle Hamilton injury updates: Ravens star DB has sprained ankle
-
Gold medalist Noah Lyles beats popular streamer IShowSpeed in 50m race